Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Johnson & Johnson's Spravato nasal spray okayed
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings
Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral antidepressants. On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray,
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral antidepressants,
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population.
Ben Johnson takes a jab at Matt LaFleur
Ben Johnson takes a jab at Matt LaFleur during introductory news conference
Bears head coach Ben Johnson makes a joke about beating Packers coach Matt LaFleur twice a season.
Schrager: Ben Johnson Called Out Matt LaFleur Despite Having No Prior Relationship
Ben Johnson got a head start on being part of the historic rivalry between the Chicago Bears and Green Bay Packers. During his introductory press
Ben Johnson takes dig at Packers coach Matt LaFleur
Ben Johnson had his choice of several jobs. He chose the Bears. Not only do they have a quarterback to build around, but Johnson also noted they are in a division with which he is familiar. Johnson spent six seasons in the NFC North as an assistant under Dan Campbell.
Lions lose Aaron Glenn, Ben Johnson to head coaching jobs
Brad Biggs: Guided by self-awareness, Ben Johnson is finally prepared for his role as head coach of the Bears
Ben Johnson launched into his virtual interview with the Chicago Bears leaving no question as to his intentions. “I want this job,” Johnson said, Chairman George McCaskey recalled. The feeling was mutual and the Bears agreed to terms with Johnson on Monday.
Lions lose Aaron Glenn, Ben Johnson to head coaching jobs: Identifying internal replacements for coordinators
Now, the Lions are also starting over at both the offensive coordinator and defensive coordinator positions on their coaching staff, with OC Ben Johnson being hired to be the next head coach of the Chicago Bears and DC Aaron Glenn being hired to be the next head coach of the New York Jets.
Chicago Bears appoint Johnson as new head coach
The Chicago Bears have appointed Ben Johnson as their new head coach. Johnson, 38, has been with the Detroit Lions since 2019 and spent the past three seasons as their offensive co-ordinator. He succeeds Matt Eberflus,
Cam Johnson, Nets blocking out trade rumors
NBA Rumors: Kings Not in Cam Johnson Talks, Will Aggressively Explore Trade Options
Don't expect the Sacramento Kings to swing a deal for Brooklyn Nets' wing Cam Johnson. According to NBA reporter Marc Stein, the Kings have been
Why Nets’ Cam Johnson is a coveted player as NBA trade deadline nears
Cam Johnson, the soon-to-be 29-year-old Brooklyn Nets wing, has been arguably their best player overall this season. Let’s explore what makes Johnson one of the hottest options on the trade market. Johnson is the 3-and-D prototype,
Nets’ Cam Johnson tuning out trade rumors swirling around him
Cam Johnson knows what time it is. Or more accurately, what time of year it is. With this a rebuilding year for the Nets, Johnson knew his name would come up in trade rumors. And with the Feb. 6 deadline just two weeks away,
13h
Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst
Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.
20h
Johnson & Johnson price target lowered to $165 from $170 at Raymond James
Raymond James lowered the firm’s price target on Johnson & Johnson to $165 from $170 and keeps an Outperform rating on the shares.
The Motley Fool
1d
Johnson & Johnson (NYSE: JNJ)
Johnson
&
Johnson
is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...
1d
on MSN
Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth
Johnson & Johnson unveiled financial results that beat Wall Street expectations as the company braces for one of its ...
20h
Johnson & Johnson: Hold Rating Amid Mixed Performance and Future Uncertainties
Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...
1d
Johnson & Johnson Tops Q4 EPS Forecasts
Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.
MassDevice
1d
Johnson & Johnson MedTech sales grow 6.2% in 2025, driven by EP, Abiomed
Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...
1d
Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond
Says starting 2025 from a position of strength. Says invested ~$50B in R&D and M&A in 2024. Says continues to invest in R&D at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback